Related Experiment Video
Updated: Sep 19, 2025

A Cell Culture Model for Studying the Role of Neuron-Glia Interactions in Ischemia
Published on: November 14, 2020
G protein and MYD Growth Factor in neuroprotection after cerebral ischemia-reperfusion
Yisheng Cheng1, Xiaoxiao Cheng2, Han Zhao1
1Department of Neurology, Wenzhou Hospital of Integrated Traditional Chinese and Western Medicine, Wenzhou, Zhejiang, China.
Purpose:
To explore the neuroprotective role of Myeloid-Derived Growth Factor (MYDGF) and its regulatory mechanisms involving G protein-coupled signaling pathways after cerebral ischemia-reperfusion injury (CIRI).
Method:
A mouse model of CIRI was established using middle cerebral artery occlusion (MCAO). Mice were divided into five groups: Mock, scramble shRNA (sh-scr), MYDGF knockdown (MYDGF-shRNA), Gαi1/3 knockdown (Gαi1/3-shRNA), and recombinant MYDGF treatment. MYDGF mRNA expression was analyzed using qRT-PCR, and protein levels were assessed via Western blot. Cell-type specific knockdown in glial cells was achieved using targeted adenoviral shRNA.
Result:
MYDGF exerted neuroprotective effects by activating PI3K-AKT-mTOR and ERK-MAPK signaling pathways. Gαi1/3 was identified as a key regulatory factor mediating these effects.
Conclusion:
MYDGF exerted neuroprotective effects by activating PI3K-AKT-mTOR and ERK-MAPK signaling pathways. Gαi1/3 was identified as a key regulatory factor mediating these effects.
Insights
Myeloid-Derived Growth Factor (MYDGF) protects the brain after stroke by activating key cell signaling pathways. Gαi1/3 is crucial for MYDGF
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Cerebral ischemia-reperfusion injury (CIRI) is a major cause of brain damage.
- Understanding the molecular mechanisms underlying neuroprotection is critical for developing effective treatments.
Purpose of the Study:
- To investigate the neuroprotective potential of Myeloid-Derived Growth Factor (MYDGF) in CIRI.
- To elucidate the role of G protein-coupled signaling pathways in MYDGF-mediated neuroprotection.
Main Methods:
- A mouse model of CIRI was established using middle cerebral artery occlusion (MCAO).
- MYDGF and Gαi1/3 expression was modulated using shRNA and recombinant protein.
- Gene and protein expression levels were analyzed using qRT-PCR and Western blot.
- Cell-type specific knockdown in glial cells was performed using adenoviral shRNA.
Main Results:
- MYDGF demonstrated significant neuroprotective effects in the CIRI model.
- Activation of PI3K-AKT-mTOR and ERK-MAPK signaling pathways was observed.
- Gαi1/3 was identified as a key mediator of MYDGF's neuroprotective actions.
Conclusions:
- MYDGF confers neuroprotection against CIRI through the PI3K-AKT-mTOR and ERK-MAPK pathways.
- Gαi1/3 plays a critical role in mediating the therapeutic effects of MYDGF.
Related Concept Videos
Activation and Inactivation of G Proteins
Neurogenesis and Regeneration of Nervous Tissue

